Show latest about:
Keep settings
  Freetext search
 Market prices
 Technology guide
 Real estate
 Israel in depth
RSS  feeds
  Search results
BioBlast Pharma IPO raises $35m on Nasdaq
The clinical-stage biotech company develops treatments for rare and ultra-rare genetic diseases.
Globes correspondent    31 Jul 14   15:24

Teva reports falling Copaxone sales, sharp rise in 40mg use
Sales of the multiple sclerosis treatment were down 12% in the second quarter.
Globes correspondent    31 Jul 14   14:58

VBL Therapeutics prices Nasdaq IPO
The biotech company is selling 5.4 million shares at $12 to raise $64.8 million.
Globes correspondent   31 Jul 14   14:14

3D Systems acquires Simbionix for $120m
Simbonix develops 3D virtual reality simulation systems to train doctors in complex surgical and treatment procedures.
Gali Weinreb   31 Jul 14   12:32

Macrocure raises $54m in Nasdaq IPO
Globes correspondent    31 Jul 14   10:03

Teva shareholders approve all proposals
Shiri Habib-Valdhorn    31 Jul 14   09:08

Yorkville invests NIS 3m in Medivie Therapeutics
Hillel Koren   30 Jul 14   13:37

BiondVax reports positive deadly avian flu results
Globes correspondent   29 Jul 14   15:54

"Donors want plaques in Tel Aviv not Beersheva"
Shay Niv   28 Jul 14   18:52

"Teva can be more aggressive with acquisitions"
Shiri Habib-Valdhorn   28 Jul 14   16:33

Mapi Pharma postpones and halves Nasdaq IPO
Gali Weinreb   28 Jul 14   16:32

Brazilian Health Ministry awards BrainStorm Cell $5m
Gali Weinreb   24 Jul 14   20:18

Protalix names Shlomo Yanai chairman
Globes correspondent   24 Jul 14   18:55

Infections treatment co Atox Bio raises $23m
Globes correspondent   24 Jul 14   14:43

For more results from our archive, Click here.